{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Alzheimer\u2019s disease", "bioactive compound", "nano-drugs", "neuroinflammation"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36558176", "DateCompleted": {"Year": "2022", "Month": "12", "Day": "26"}, "DateRevised": {"Year": "2022", "Month": "12", "Day": "26"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "12", "Day": "19"}], "Language": ["eng"], "ELocationID": ["9043", "10.3390/molecules27249043"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "27", "Issue": "24", "PubDate": {"Year": "2022", "Month": "Dec", "Day": "19"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Phytochemical Compounds and Nanoparticles as Phytochemical Delivery Systems for Alzheimer's Disease Management.", "Abstract": {"AbstractText": ["Alzheimer's disease remains one of the most widespread neurodegenerative reasons for dementia worldwide and is associated with considerable mortality and morbidity. Therefore, it has been considered a priority for research. Indeed, several risk factors are involved in the complexity of the therapeutic ways of this pathology, including age, traumatic brain injury, genetics, exposure to aluminum, infections, diabetes, vascular diseases, hypertension, dyslipidemia, and obesity. The pathophysiology of Alzheimer's disease is mostly associated with hyperphosphorylated protein in the neuronal cytoplasm and extracellular plaques of the insoluble \u03b2-amyloid peptide. Therefore, the management of this pathology needs the screening of drugs targeting different pathological levels, such as acetylcholinesterase (AchE), amyloid <i>\u03b2</i> formation, and lipoxygenase inhibitors. Among the pharmacological strategies used for the management of Alzheimer's disease, natural drugs are considered a promising therapeutic strategy. Indeed, bioactive compounds isolated from different natural sources exhibit important anti-Alzheimer effects by their effectiveness in promoting neuroplasticity and protecting against neurodegeneration as well as neuroinflammation and oxidative stress in the brain. These effects involve different sub-cellular, cellular, and/or molecular mechanisms, such as the inhibition of acetylcholinesterase (AchE), the modulation of signaling pathways, and the inhibition of oxidative stress. Moreover, some nanoparticles were recently used as phytochemical delivery systems to improve the effects of phytochemical compounds against Alzheimer's disease. Therefore, the present work aims to provide a comprehensive overview of the key advances concerning nano-drug delivery applications of phytochemicals for Alzheimer's disease management."]}, "AuthorList": [{"Identifier": ["0000-0002-4521-3515"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Geo-Bio-Environment Engineering and Innovation Laboratory, Molecular Engineering, Biotechnology and Innovation Team, Polydisciplinary Faculty of Taroudant, Ibn Zohr University, Agadir 80000, Morocco."}], "LastName": "Bakrim", "ForeName": "Saad", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Physiology and Physiopathology Team, Faculty of Sciences, Genomic of Human Pathologies Research, Mohammed V University in Rabat, Rabat 10100, Morocco."}], "LastName": "Aboulaghras", "ForeName": "Sara", "Initials": "S"}, {"Identifier": ["0000-0002-4842-2056"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Pharmacology, National Agency of Medicinal and Aromatic Plants, Taounate 34025, Morocco."}], "LastName": "El Menyiy", "ForeName": "Naoual", "Initials": "N"}, {"Identifier": ["0000-0002-0308-1155"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Histology, Embryology and Cytogenetic, Faculty of Medicine and Pharmacy, Mohammed V University in Rabat, Rabat 10100, Morocco."}], "LastName": "El Omari", "ForeName": "Nasreddine", "Initials": "N"}, {"Identifier": ["0000-0001-5563-9491"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Laboratory Medicine, Faculty of Applied Medical Sciences, Umm Al-Qura University, Makkah 21955, Saudi Arabia."}], "LastName": "Assaggaf", "ForeName": "Hamza", "Initials": "H"}, {"Identifier": ["0000-0002-8589-7456"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Novel Bacteria and Drug Discovery Research Group (NBDD), Microbiome and Bioresource Research Strength (MBRS), Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Subang Jaya 47500, Malaysia."}], "LastName": "Lee", "ForeName": "Learn-Han", "Initials": "LH"}, {"Identifier": ["0000-0002-8857-2091"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, University of Naples Federico II, Via D. Montesano 49, 80131 Naples, Italy."}], "LastName": "Montesano", "ForeName": "Domenico", "Initials": "D"}, {"Identifier": ["0000-0001-6281-426X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Via Pansini 5, 80131 Naples, Italy."}], "LastName": "Gallo", "ForeName": "Monica", "Initials": "M"}, {"Identifier": ["0000-0001-6548-7823"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biology, Science Faculty, Selcuk University, 42130 Konya, Turkey."}], "LastName": "Zengin", "ForeName": "Gokhan", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biology, College of Science, United Arab Emirates University, Al Ain 15551, United Arab Emirates."}], "LastName": "AlDhaheri", "ForeName": "Yusra", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Human Pathologies Biology, Department of Biology, Faculty of Sciences, Mohammed V University in Rabat, Rabat 10106, Morocco."}], "LastName": "Bouyahya", "ForeName": "Abdelhakim", "Initials": "A"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Amyloid beta-Peptides"}, {"RegistryNumber": "EC 3.1.1.7", "NameOfSubstance": "Acetylcholinesterase"}, {"RegistryNumber": "0", "NameOfSubstance": "Phytochemicals"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["metabolism"], "DescriptorName": "Alzheimer Disease"}, {"QualifierName": ["metabolism"], "DescriptorName": "Amyloid beta-Peptides"}, {"QualifierName": ["metabolism"], "DescriptorName": "Acetylcholinesterase"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Phytochemicals"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Nanoparticles"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Silva M.V.F., Loures C.d.M.G., Alves L.C.V., de Souza L.C., Borges K.B.G., Carvalho M.d.G. Alzheimer\u2019s disease: Risk factors and potentially protective measures. J. Biomed. Sci. 2019;26:33. doi: 10.1186/s12929-019-0524-y.", "ArticleIdList": ["10.1186/s12929-019-0524-y", "PMC6507104", "31072403"]}, {"Citation": "Abreu I.D.d., Forlenza O.V., Barros H.L.d. Alzheimer disease: Correlation between memory and autonomy. Arch. Clin. Psychiatry (S\u00e3o Paulo) 2005;32:131\u2013136. doi: 10.1590/S0101-60832005000300005.", "ArticleIdList": ["10.1590/S0101-60832005000300005"]}, {"Citation": "Lauretti E., Dincer O., Pratic\u00f2 D. Glycogen synthase kinase-3 signaling in Alzheimer\u2019s disease. Biochim. Biophys. (BBA)\u2014Mol. Basis Dis. 2020;1867:118664. doi: 10.1016/j.bbamcr.2020.118664.", "ArticleIdList": ["10.1016/j.bbamcr.2020.118664", "PMC7047718", "32006534"]}, {"Citation": "Ju J., Xie Y., Yu H., Guo Y., Cheng Y., Qian H., Yao W. Synergistic interactions of plant essential oils with antimicrobial agents: A new antimicrobial therapy. Crit. Rev. Food Sci. Nutr. 2022;62:1740\u20131751. doi: 10.1080/10408398.2020.1846494.", "ArticleIdList": ["10.1080/10408398.2020.1846494", "33207954"]}, {"Citation": "Mucke L. NEUROSCIENCE Alzheimer\u2019s disease. Nature. 2009;461:895\u2013897. doi: 10.1038/461895a.", "ArticleIdList": ["10.1038/461895a", "19829367"]}, {"Citation": "Belwal T., Nabavi S.M., Nabavi S.F., Dehpour A.R., Shirooie S. Naturally Occurring Chemicals against Alzheimer\u2019s Disease. Academic Press; Cambridge, MA, USA: 2020."}, {"Citation": "Bouyahya A., Abrini J., Bakri Y., Dakka N. Screening phytochimique et \u00e9valuation de l\u2019activit\u00e9 antioxydante et antibact\u00e9rienne des extraits d\u2019Origanum compactum. Phytoth\u00e9rapie. 2017;15:379\u2013383. doi: 10.1007/s10298-017-1101-8.", "ArticleIdList": ["10.1007/s10298-017-1101-8"]}, {"Citation": "Balahbib A., El Omari N., Hachlafi N.E., Lakhdar F., El Menyiy N., Salhi N., Mrabti H.N., Bakrim S., Zengin G., Bouyahya A. Health beneficial and pharmacological properties of p-cymene. Food Chem. Toxicol. 2021;153:112259. doi: 10.1016/j.fct.2021.112259.", "ArticleIdList": ["10.1016/j.fct.2021.112259", "33984423"]}, {"Citation": "Benali T., Bouyahya A., Habbadi K., Zengin G., Khabbach A., Achbani E.H., Hammani K. Chemical composition and antibacterial activity of the essential oil and extracts of Cistus ladaniferus subsp. ladanifer and Mentha suaveolens against phytopathogenic bacteria and their ecofriendly management of phytopathogenic bacteria. Biocatal. Agric. Biotechnol. 2020;28:101696. doi: 10.1016/j.bcab.2020.101696.", "ArticleIdList": ["10.1016/j.bcab.2020.101696"]}, {"Citation": "Salehi B., Quispe C., Chamkhi I., El Omari N., Balahbib A., Sharifi-Rad J., Bouyahya A., Akram M., Iqbal M., Docea A.O. Pharmacological properties of chalcones: A review of preclinical including molecular mechanisms and clinical evidence. Front. Pharmacol. 2021;11:592654. doi: 10.3389/fphar.2020.592654.", "ArticleIdList": ["10.3389/fphar.2020.592654", "PMC7849684", "33536909"]}, {"Citation": "Marmouzi I., Bouyahya A., Ezzat S.M., El Jemli M., Kharbach M. The food plant Silybum marianum (L.) Gaertn.: Phytochemistry, Ethnopharmacology and clinical evidence. J. Ethnopharmacol. 2021;265:113303. doi: 10.1016/j.jep.2020.113303.", "ArticleIdList": ["10.1016/j.jep.2020.113303", "32877720"]}, {"Citation": "Mir R.H., Shah A.J., Mohi-Ud-Din R., Pottoo F.H., Dar M.A., Jachak S.M., Masoodi M.H. Natural Anti-inflammatory compounds as Drug candidates in Alzheimer\u2019s disease. Curr. Med. Chem. 2021;28:4799\u20134825. doi: 10.2174/0929867327666200730213215.", "ArticleIdList": ["10.2174/0929867327666200730213215", "32744957"]}, {"Citation": "Seo E.-J., Fischer N., Efferth T. Phytochemicals as inhibitors of NF-\u03baB for treatment of Alzheimer\u2019s disease. Pharmacol. Res. 2018;129:262\u2013273. doi: 10.1016/j.phrs.2017.11.030.", "ArticleIdList": ["10.1016/j.phrs.2017.11.030", "29179999"]}, {"Citation": "Patra J.K., Das G., Fraceto L.F., Campos E.V.R., Rodriguez-Torres M.d.P., Acosta-Torres L.S., Diaz-Torres L.A., Grillo R., Swamy M.K., Sharma S., et al. Nano based drug delivery systems: Recent developments and future prospects. J. Nanobiotechnol. 2018;16:71. doi: 10.1186/s12951-018-0392-8.", "ArticleIdList": ["10.1186/s12951-018-0392-8", "PMC6145203", "30231877"]}, {"Citation": "Kashyap D., Tuli H.S., Yerer M.B., Sharma A., Sak K., Srivastava S., Pandey A., Garg V.K., Sethi G., Bishayee A. Natural product-based nanoformulations for cancer therapy: Opportunities and challenges. Semin. Cancer Biol. 2021;69:5\u201323. doi: 10.1016/j.semcancer.2019.08.014.", "ArticleIdList": ["10.1016/j.semcancer.2019.08.014", "31421264"]}, {"Citation": "Enrico C. Chapter 3\u2014Nanotechnology-Based Drug Delivery of Natural Compounds and Phytochemicals for the Treatment of Cancer and Other Diseases. In: Atta-ur-Rahman, editor. Studies in Natural Products Chemistry. Volume 62. Elsevier; Amsterdam, The Netherlands: 2019. pp. 91\u2013123."}, {"Citation": "Hoyer S. Causes and consequences of disturbances of cerebral glucose metabolism in sporadic Alzheimer disease: Therapeutic implications. Front. Clin. Neurosci. 2004;541:135\u2013152.", "ArticleIdList": ["14977212"]}, {"Citation": "Hoyer S. Brain glucose and energy metabolism abnormalities in sporadic Alzheimer disease. Causes and consequences: An update. Exp. Gerontol. 2000;35:1363\u20131372. doi: 10.1016/S0531-5565(00)00156-X.", "ArticleIdList": ["10.1016/S0531-5565(00)00156-X", "11113614"]}, {"Citation": "Parihar M.S., Brewer G.J. Mitoenergetic failure in Alzheimer disease. Am. J. Physiol. Cell Physiol. 2007;292:C8\u2013C23. doi: 10.1152/ajpcell.00232.2006.", "ArticleIdList": ["10.1152/ajpcell.00232.2006", "16807300"]}, {"Citation": "Liu Y., Liu F., Iqbal K., Grundke-Iqbal I., Gong C.-X. Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease. FEBS Lett. 2008;582:359\u2013364. doi: 10.1016/j.febslet.2007.12.035.", "ArticleIdList": ["10.1016/j.febslet.2007.12.035", "PMC2247364", "18174027"]}, {"Citation": "Hardy J.A., Higgins G.A. Alzheimer\u2019s disease: The amyloid cascade hypothesis. Science. 1992;256:184\u2013185. doi: 10.1126/science.1566067.", "ArticleIdList": ["10.1126/science.1566067", "1566067"]}, {"Citation": "Herrup K. Reimagining Alzheimer\u2019s disease\u2014An age-based hypothesis. J. Neurosci. 2010;30:16755\u201316762. doi: 10.1523/JNEUROSCI.4521-10.2010.", "ArticleIdList": ["10.1523/JNEUROSCI.4521-10.2010", "PMC3004746", "21159946"]}, {"Citation": "Khachaturian Z.S. Diagnosis of Alzheimer\u2019s disease. Arch. Neurol. 1985;42:1097\u20131105. doi: 10.1001/archneur.1985.04060100083029.", "ArticleIdList": ["10.1001/archneur.1985.04060100083029", "2864910"]}, {"Citation": "Mirra S.S., Heyman A., McKeel D., Sumi S.M., Crain B.J., Brownlee L.M., Vogel F.S., Hughes J.P., Van Belle G., Berg L., et al. The Consortium to Establish a Registry for Alzheimer\u2019s Disease (CERAD): Part II. Standardization of the neuropathologic assessment of Alzheimer\u2019s disease. Neurology. 1991;41:479. doi: 10.1212/WNL.41.4.479.", "ArticleIdList": ["10.1212/WNL.41.4.479", "2011243"]}, {"Citation": "Zempel H., Mandelkow E. Lost after translation: Missorting of Tau protein and consequences for Alzheimer disease. Trends Neurosci. 2014;37:721\u2013732. doi: 10.1016/j.tins.2014.08.004.", "ArticleIdList": ["10.1016/j.tins.2014.08.004", "25223701"]}, {"Citation": "Kumar A., Tsao J.W. Alzheimer Disease. StatPearls; Treasure Island, FL, USA: 2018."}, {"Citation": "Heneka M.T., Carson M.J., El Khoury J., Landreth G.E., Brosseron F., Feinstein D.L., Jacobs A.H., Wyss-Coray T., Vitorica J., Ransohoff R.M., et al. Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol. 2015;14:388\u2013405. doi: 10.1016/S1474-4422(15)70016-5.", "ArticleIdList": ["10.1016/S1474-4422(15)70016-5", "PMC5909703", "25792098"]}, {"Citation": "Chen Z., Zhong C. Oxidative stress in Alzheimer\u2019s disease. Neurosci. Bull. 2014;30:271\u2013281. doi: 10.1007/s12264-013-1423-y.", "ArticleIdList": ["10.1007/s12264-013-1423-y", "PMC5562667", "24664866"]}, {"Citation": "Wang X., Wang W., Li L., Perry G., Lee H.-G., Zhu X. Oxidative stress and mitochondrial dysfunction in Alzheimer\u2019s disease. Biochim. Biophys. (BBA)\u2014Mol. Basis Dis. 2014;1842:1240\u20131247. doi: 10.1016/j.bbadis.2013.10.015.", "ArticleIdList": ["10.1016/j.bbadis.2013.10.015", "PMC4007397", "24189435"]}, {"Citation": "DuBoff B., Feany M., G\u00f6tz J. Why size matters\u2013balancing mitochondrial dynamics in Alzheimer\u2019s disease. Trends Neurosci. 2013;36:325\u2013335. doi: 10.1016/j.tins.2013.03.002.", "ArticleIdList": ["10.1016/j.tins.2013.03.002", "23582339"]}, {"Citation": "Campos-Pena V., Toral-Rios D., Becerril-P\u00e9rez F., S\u00e1nchez-Torres C., Delgado-Namorado Y., Torres-Ossorio E., Franco-Bocanegra D., Carvajal K. Metabolic syndrome as a risk factor for Alzheimer\u2019s disease: Is A\u03b2 a crucial factor in both pathologies? Antioxid. Redox Signal. 2017;26:542\u2013560. doi: 10.1089/ars.2016.6768.", "ArticleIdList": ["10.1089/ars.2016.6768", "27368351"]}, {"Citation": "Dik M.G., Jonker C., Comijs H.C., Deeg D.J., Kok A., Yaffe K., Penninx B.W. Contribution of metabolic syndrome components to cognition in older individuals. Diabetes Care. 2007;30:2655\u20132660. doi: 10.2337/dc06-1190.", "ArticleIdList": ["10.2337/dc06-1190", "17563341"]}, {"Citation": "Butterfield D.A., Lauderback C.M. Lipid peroxidation and protein oxidation in Alzheimer\u2019s disease brain: Potential causes and consequences involving amyloid \u03b2-peptide-associated free radical oxidative stress1, 2. Free Radic. Biol. Med. 2002;32:1050\u20131060. doi: 10.1016/S0891-5849(02)00794-3.", "ArticleIdList": ["10.1016/S0891-5849(02)00794-3", "12031889"]}, {"Citation": "Uttara B., Singh A.V., Zamboni P., Mahajan R.T. Oxidative stress and neurodegenerative diseases: A review of upstream and downstream antioxidant therapeutic options. Curr. Neuropharmacol. 2009;7:65\u201374. doi: 10.2174/157015909787602823.", "ArticleIdList": ["10.2174/157015909787602823", "PMC2724665", "19721819"]}, {"Citation": "Castellani R., Hirai K., Aliev G., Drew K.L., Nunomura A., Takeda A., Cash A.D., Obrenovich M.E., Perry G., Smith M.A. Role of mitochondrial dysfunction in Alzheimer\u2019s disease. J. Neurosci. Res. 2002;70:357\u2013360. doi: 10.1002/jnr.10389.", "ArticleIdList": ["10.1002/jnr.10389", "12391597"]}, {"Citation": "Gibson G.E., Sheu K.-F.R., Blass J.P. Abnormalities of mitochondrial enzymes in Alzheimer disease. J. Neural Transm. 1998;105:855\u2013870. doi: 10.1007/s007020050099.", "ArticleIdList": ["10.1007/s007020050099", "9869323"]}, {"Citation": "Tang Y., Lutz M.W., Xing Y. A systems-based model of Alzheimer\u2019s disease. Alzheimer\u2019s Dement. 2019;15:168\u2013171. doi: 10.1016/j.jalz.2018.06.3058.", "ArticleIdList": ["10.1016/j.jalz.2018.06.3058", "30102884"]}, {"Citation": "Apostolova L.G. Alzheimer disease. Contin. Lifelong Learn. Neurol. 2016;22:419. doi: 10.1212/CON.0000000000000307.", "ArticleIdList": ["10.1212/CON.0000000000000307", "PMC5390933", "27042902"]}, {"Citation": "Bonda D.J., Wang X., Perry G., Nunomura A., Tabaton M., Zhu X., Smith M.A. Oxidative stress in Alzheimer disease: A possibility for prevention. Neuropharmacology. 2010;59:290\u2013294. doi: 10.1016/j.neuropharm.2010.04.005.", "ArticleIdList": ["10.1016/j.neuropharm.2010.04.005", "20394761"]}, {"Citation": "Mendez M.F. Early-onset Alzheimer disease and its variants. Contin. Lifelong Learn. Neurol. 2019;25:34. doi: 10.1212/CON.0000000000000687.", "ArticleIdList": ["10.1212/CON.0000000000000687", "PMC6538053", "30707186"]}, {"Citation": "Bird T.D. Alzheimer Disease Overview. GeneReviews\u00ae[Internet]  [(accessed on 5 November 2022)];2018  Available online:  https://www.ncbi.nlm.nih.gov/books/NBK1161/"}, {"Citation": "Samanta M.K., Wilson B., Santhi K., Kumar K.S., Suresh B. Alzheimer disease and its management: A review. Am. J. Ther. 2006;13:516\u2013526. doi: 10.1097/01.mjt.0000208274.80496.f1.", "ArticleIdList": ["10.1097/01.mjt.0000208274.80496.f1", "17122533"]}, {"Citation": "Cacabelos R. Donepezil in Alzheimer\u2019s disease: From conventional trials to pharmacogenetics. Neuropsychiatr. Dis. Treat. 2007;3:303\u2013333.", "ArticleIdList": ["PMC2654795", "19300564"]}, {"Citation": "Li Q., He S., Chen Y., Feng F., Qu W., Sun H. Donepezil-based multi-functional cholinesterase inhibitors for treatment of Alzheimer\u2019s disease. Eur. J. Med. Chem. 2018;158:463\u2013477. doi: 10.1016/j.ejmech.2018.09.031.", "ArticleIdList": ["10.1016/j.ejmech.2018.09.031", "30243151"]}, {"Citation": "Zhang N., Gordon M.L. Clinical efficacy and safety of donepezil in the treatment of Alzheimer\u2019s disease in Chinese patients. Clin. Interv. Aging. 2018;13:1963\u20131970. doi: 10.2147/CIA.S159920.", "ArticleIdList": ["10.2147/CIA.S159920", "PMC6187917", "30349215"]}, {"Citation": "Wake R., Araki T., Miyaoka T., Nagahama M., Furuya M., Hayashida M., Hashioka S., Horiguchi J. Long-Term Effects Of Combined Treatment With Memantine And Donepezil On Alzheimer\u2019s Disease Patients: 72-Week Study. Neuropsychiatry. 2018;8:951\u2013960. doi: 10.4172/Neuropsychiatry.1000421.", "ArticleIdList": ["10.4172/Neuropsychiatry.1000421"]}, {"Citation": "Matsunaga S., Kishi T., Nomura I., Sakuma K., Okuya M., Ikuta T., Iwata N. The efficacy and safety of memantine for the treatment of Alzheimer\u2019s disease. Expert Opin. Drug Saf. 2018;17:1053\u20131061. doi: 10.1080/14740338.2018.1524870.", "ArticleIdList": ["10.1080/14740338.2018.1524870", "30222469"]}, {"Citation": "Bautista-Aguilera \u00d3.M., Ismaili L., Iriepa I., Diez-Iriepa D., Chabchoub F., Marco-Contelles J., P\u00e9rez M. Tacrines as therapeutic agents for alzheimer\u2019s disease. V. recent developments. Chem. Rec. 2021;21:162\u2013174. doi: 10.1002/tcr.202000107.", "ArticleIdList": ["10.1002/tcr.202000107", "33169934"]}, {"Citation": "Khoury R., Rajamanickam J., Grossberg G.T. An update on the safety of current therapies for Alzheimer\u2019s disease: Focus on rivastigmine. Ther. Adv. Drug Saf. 2018;9:171\u2013178. doi: 10.1177/2042098617750555.", "ArticleIdList": ["10.1177/2042098617750555", "PMC5810854", "29492246"]}, {"Citation": "Ray B., Maloney B., Sambamurti K., Karnati H.K., Nelson P.T., Greig N.H., Lahiri D.K. Rivastigmine modifies the \u03b1-secretase pathway and potentially early Alzheimer\u2019s disease. Transl. Psychiatry. 2020;10:47. doi: 10.1038/s41398-020-0709-x.", "ArticleIdList": ["10.1038/s41398-020-0709-x", "PMC7026402", "32066688"]}, {"Citation": "Yiannopoulou K.G., Papageorgiou S.G. Current and future treatments in Alzheimer disease: An update. J. Central Nerv. Syst. Dis. 2020;12:1179573520907397. doi: 10.1177/1179573520907397.", "ArticleIdList": ["10.1177/1179573520907397", "PMC7050025", "32165850"]}, {"Citation": "Cammisuli D.M., Danti S., Bosinelli F., Cipriani G. Non-pharmacological interventions for people with Alzheimer\u2019s Disease: A critical review of the scientific literature from the last ten years. Eur. Geriatr. Med. 2016;7:57\u201364. doi: 10.1016/j.eurger.2016.01.002.", "ArticleIdList": ["10.1016/j.eurger.2016.01.002"]}, {"Citation": "Hayashi T., Ohnishi T., Okabe S., Teramoto N., Nonaka Y., Watabe H., Imabayashi E., Ohta Y., Jino H., Ejima N., et al. Long-term effect of motor cortical repetitive transcranial magnetic stimulation induces. Ann. Neurol. 2004;56:77\u201385. doi: 10.1002/ana.20151.", "ArticleIdList": ["10.1002/ana.20151", "15236404"]}, {"Citation": "Sol\u00e9-Padull\u00e9s C., Bartr\u00e9s-Faz D., Junqu\u00e9 C., Clemente I.C., Molinuevo J.L., Bargall\u00f3 N., S\u00e1nchez-Aldeguer J., Bosch B., Falc\u00f3n C., Valls-Sol\u00e9 J. Repetitive transcranial magnetic stimulation effects on brain function and cognition among elders with memory dysfunction. A randomized sham-controlled study. Cerebr. Cortex. 2006;16:1487\u20131493. doi: 10.1093/cercor/bhj083.", "ArticleIdList": ["10.1093/cercor/bhj083", "16339086"]}, {"Citation": "Cotelli M., Manenti R., Cappa S.F., Zanetti O., Miniussi C. Transcranial magnetic stimulation improves naming in Alzheimer disease patients at different stages of cognitive decline. Eur. J. Neurol. 2008;15:1286\u20131292. doi: 10.1111/j.1468-1331.2008.02202.x.", "ArticleIdList": ["10.1111/j.1468-1331.2008.02202.x", "19049544"]}, {"Citation": "Wang L.-Y., Pei J., Zhan Y.-J., Cai Y.-W. Overview of meta-analyses of five non-pharmacological interventions for Alzheimer\u2019s disease. Front. Aging Neurosci. 2020;12:594432. doi: 10.3389/fnagi.2020.594432.", "ArticleIdList": ["10.3389/fnagi.2020.594432", "PMC7723835", "33324194"]}, {"Citation": "Bahar-Fuchs A., Martyr A., Goh A.M., Sabates J., Clare L. Cognitive training for people with mild to moderate dementia. Cochrane Database Syst. Rev. 2019 doi: 10.1002/14651858.CD013069.pub2.", "ArticleIdList": ["10.1002/14651858.CD013069.pub2", "PMC6433473", "30909318"]}, {"Citation": "Tsantali E., Economidis D., Rigopoulou S. Testing the benefits of cognitive training vs. cognitive stimulation in mild Alzheimer\u2019s disease: A randomised controlled trial. Brain Impair. 2017;18:188\u2013196. doi: 10.1017/BrImp.2017.6.", "ArticleIdList": ["10.1017/BrImp.2017.6"]}, {"Citation": "Clare L., Bayer A., Burns A., Corbett A., Jones R., Knapp M., Kopelman M., Kudlicka A., Leroi I., Oyebode J., et al. Goal-oriented cognitive rehabilitation in early-stage dementia: Study protocol for a multi-centre single-blind randomised controlled trial (GREAT) Trials. 2013;14:152. doi: 10.1186/1745-6215-14-152.", "ArticleIdList": ["10.1186/1745-6215-14-152", "PMC3680175", "23710796"]}, {"Citation": "Ryu S.-H. The clinical significance of cognitive interventions for the patients with mild cognitive impairment. J. Korean Neuropsychiatr. Assoc. 2018;57:23\u201329. doi: 10.4306/jknpa.2018.57.1.23.", "ArticleIdList": ["10.4306/jknpa.2018.57.1.23"]}, {"Citation": "Bruer R.A., Spitznagel E., Cloninger C.R. The temporal limits of cognitive change from music therapy in elderly persons with dementia or dementia-like cognitive nmpairment: A randomized controlled trial. J. Music Ther. 2007;44:308\u2013328. doi: 10.1093/jmt/44.4.308.", "ArticleIdList": ["10.1093/jmt/44.4.308", "17997623"]}, {"Citation": "Ozdemir L., Akdemir N. Effects of multisensory stimulation on cognition, depression and anxiety levels of mildly-affected Alzheimer\u2019s patients. J. Neurol. Sci. 2009;283:211\u2013213. doi: 10.1016/j.jns.2009.02.367.", "ArticleIdList": ["10.1016/j.jns.2009.02.367", "19289242"]}, {"Citation": "S\u00e4rk\u00e4m\u00f6 T., Tervaniemi M., Laitinen S., Numminen A., Kurki M., Johnson J.K., Rantanen P. Cognitive, emotional, and social benefits of regular musical activities in early dementia: Randomized controlled study. Gerontologist. 2014;54:634\u2013650. doi: 10.1093/geront/gnt100.", "ArticleIdList": ["10.1093/geront/gnt100", "24009169"]}, {"Citation": "Satoh M., Yuba T., Tabei K., Okubo Y., Kida H., Sakuma H., Tomimoto H. Music therapy using singing training improves psychomotor speed in patients with Alzheimer\u2019s disease: A neuropsychological and fMRI study. Dement. Geriatr. Cogn. Disord. Extra. 2015;5:296\u2013308. doi: 10.1159/000436960.", "ArticleIdList": ["10.1159/000436960", "PMC4608626", "26483829"]}, {"Citation": "Gallego M.G., Garc\u00eda J.G. Music therapy and Alzheimer\u2019s disease: Cognitive, psychological, and behavioural effects. Neurolog\u00eda. 2017;32:300\u2013308. doi: 10.1016/j.nrleng.2015.12.001.", "ArticleIdList": ["10.1016/j.nrleng.2015.12.001", "26896913"]}, {"Citation": "Rubia Ort\u00ed J.E.d.l., Garc\u00eda-Pardo M.P., Iranzo C.C., Madrigal J.J.C., Castillo S.S., Rochina M.J., Gasc\u00f3 V.J.P. Does music therapy improve anxiety and depression in alzheimer\u2019s patients? J. Altern. Complement. Med. 2018;24:33\u201336. doi: 10.1089/acm.2016.0346.", "ArticleIdList": ["10.1089/acm.2016.0346", "28714736"]}, {"Citation": "Lyu J., Zhang J., Mu H., Li W., Champ M., Xiong Q., Gao T., Xie L., Jin W., Yang W. The effects of music therapy on cognition, psychiatric symptoms, and activities of daily living in patients with Alzheimer\u2019s disease. J. Alzheimer\u2019s Dis. 2018;64:1347\u20131358. doi: 10.3233/JAD-180183.", "ArticleIdList": ["10.3233/JAD-180183", "29991131"]}, {"Citation": "Peck K.J., Girard T.A., Russo F.A., Fiocco A.J. Music and memory in Alzheimer\u2019s disease and the potential underlying mechanisms. J. Alzheimer\u2019s Dis. 2016;51:949\u2013959. doi: 10.3233/JAD-150998.", "ArticleIdList": ["10.3233/JAD-150998", "26967216"]}, {"Citation": "Zhu X., Zhang H., Lo R. Phenolic compounds from the leaf extract of artichoke (Cynara scolymus L.) and their antimicrobial activities. J. Agric. Food Chem. 2004;52:7272\u20137278. doi: 10.1021/jf0490192.", "ArticleIdList": ["10.1021/jf0490192", "15563206"]}, {"Citation": "Zhang B., Carroll J., Trojanowski J.Q., Yao Y., Iba M., Potuzak J.S., Hogan A.-M.L., Xie S.X., Ballatore C., Smith A.B., et al. The microtubule-stabilizing agent, epothilone D, reduces axonal dysfunction, neurotoxicity, cognitive deficits, and Alzheimer-like pathology in an interventional study with aged tau transgenic mice. J. Neurosci. 2012;32:3601\u20133611. doi: 10.1523/JNEUROSCI.4922-11.2012.", "ArticleIdList": ["10.1523/JNEUROSCI.4922-11.2012", "PMC3321513", "22423084"]}, {"Citation": "Bahar-Fuchs A., Clare L., Woods B. Cognitive training and cognitive rehabilitation for mild to moderate Alzheimer\u2019s disease and vascular dementia. Cochrane Database Syst. Rev. 2013;2013:CD003260. doi: 10.1002/14651858.CD003260.pub2.", "ArticleIdList": ["10.1002/14651858.CD003260.pub2", "PMC7144738", "23740535"]}, {"Citation": "Heppner F.L., Ransohoff R.M., Becher B. Immune attack: The role of inflammation in Alzheimer disease. Nat. Rev. Neurosci. 2015;16:358\u2013372. doi: 10.1038/nrn3880.", "ArticleIdList": ["10.1038/nrn3880", "25991443"]}, {"Citation": "Bajpai S., Tripathi M., Pandey R.M., Dey A.B., Nehra A. Development and validation of Cognitive Training Intervention for Alzheimer\u2019s disease (CTI-AD): A picture-based interventional program. Dementia. 2020;19:1203\u20131219. doi: 10.1177/1471301218797043.", "ArticleIdList": ["10.1177/1471301218797043", "30180764"]}, {"Citation": "Ahmad S.S., Waheed T., Rozeen S., Mahmood S., Kamal M.A. Therapeutic study of phytochemicals against cancer and alzheimer\u2019s disease management. Curr. Drug Metab. 2019;20:1006\u20131013. doi: 10.2174/1389200221666200103092719.", "ArticleIdList": ["10.2174/1389200221666200103092719", "31902351"]}, {"Citation": "Y\u0131lmaz A., Bo\u011fa M., Top\u00e7u G. Novel Terpenoids with Potential Anti-Alzheimer Activity from. Rec. Nat. Prod. 2016;10:530\u2013541."}, {"Citation": "Dash U.C., Kanhar S., Dixit A., Dandapat J., Sahoo A.K. Isolation, identification, and quantification of Pentylcurcumene from Geophila repens: A new class of cholinesterase inhibitor for Alzheimer\u2019s disease. Bioorganic Chem. 2019;88:102947. doi: 10.1016/j.bioorg.2019.102947.", "ArticleIdList": ["10.1016/j.bioorg.2019.102947", "31028989"]}, {"Citation": "Xu J., Wang F., Guo J., Xu C., Cao Y., Fang Z., Wang Q. Pharmacological Mechanisms Underlying the Neuroprotective Effects of Alpinia oxyphylla Miq. on Alzheimer\u2019s Disease. Int. J. Mol. Sci. 2020;21:2071. doi: 10.3390/ijms21062071.", "ArticleIdList": ["10.3390/ijms21062071", "PMC7139528", "32197305"]}, {"Citation": "Montenegro Z.J.S., \u00c1lvarez-Rivera G., S\u00e1nchez-Mart\u00ednez J.D., Gallego R., Vald\u00e9s A., Bueno M., Cifuentes A., Ib\u00e1\u00f1ez E. Neuroprotective Effect of Terpenoids Recovered from Olive Oil By-Products. Foods. 2021;10:1507. doi: 10.3390/foods10071507.", "ArticleIdList": ["10.3390/foods10071507", "PMC8306477", "34209864"]}, {"Citation": "Rocamora C.R., Ramasamy K., Lim S.M., Majeed A.B.A., Agatonovic-Kustrin S. HPTLC based approach for bioassay-guided evaluation of antidiabetic and neuroprotective effects of eight essential oils of the Lamiaceae family plants. J. Pharm. Biomed. Anal. 2020;178:112909. doi: 10.1016/j.jpba.2019.112909.", "ArticleIdList": ["10.1016/j.jpba.2019.112909", "31618702"]}, {"Citation": "Shin M., Liu Q.F., Choi B., Shin C., Lee B., Yuan C., Song Y.J., Yun H.S., Lee I.-S., Koo B.-S., et al. Neuroprotective Effects of Limonene (+) against A\u03b242-Induced Neurotoxicity in a Drosophila Model of Alzheimer\u2019s Disease. Biol. Pharm. Bull. 2020;43:409\u2013417. doi: 10.1248/bpb.b19-00495.", "ArticleIdList": ["10.1248/bpb.b19-00495", "31875578"]}, {"Citation": "Ng Y.P., Or T.C.T., Ip N.Y. Plant alkaloids as drug leads for Alzheimer\u2019s disease. Neurochem. Int. 2015;89:260\u2013270. doi: 10.1016/j.neuint.2015.07.018.", "ArticleIdList": ["10.1016/j.neuint.2015.07.018", "26220901"]}, {"Citation": "Konrath E.L., Passos C.d.S., Klein-J\u00fanior L.C., Henriques A.T. Alkaloids as a source of potential anticholinesterase inhibitors for the treatment of Alzheimer\u2019s disease. J. Pharm. Pharm. 2013;65:1701\u20131725. doi: 10.1111/jphp.12090.", "ArticleIdList": ["10.1111/jphp.12090", "24236981"]}, {"Citation": "Zangara A. The psychopharmacology of huperzine A: An alkaloid with cognitive enhancing and neuroprotective properties of interest in the treatment of Alzheimer\u2019s disease. Pharmacol. Biochem. Behav. 2003;75:675\u2013686. doi: 10.1016/S0091-3057(03)00111-4.", "ArticleIdList": ["10.1016/S0091-3057(03)00111-4", "12895686"]}, {"Citation": "Kita Y., Ago Y., Higashino K., Asada K., Takano E., Takuma K., Matsuda T. Galantamine promotes adult hippocampal neurogenesis via M1 muscarinic and \u03b1 7 nicotinic receptors in mice. Int. J. Neuropsychopharmacol. 2014;17:1957\u20131968. doi: 10.1017/S1461145714000613.", "ArticleIdList": ["10.1017/S1461145714000613", "24818616"]}, {"Citation": "Dall\u2019Acqua S. Plant-derived acetylcholinesterase inhibitory alkaloids for the treatment of Alzheimer\u2019s disease. Bot. Targets Ther. 2013;3:19\u201328. doi: 10.2147/BTAT.S17297.", "ArticleIdList": ["10.2147/BTAT.S17297"]}, {"Citation": "Choudhary M.I., Nawaz S.A., Haq Z.-u., Azim M.K., Ghayur M.N., Lodhi M.A., Jalil S., Khalid A., Ahmed A., Rode B.M., et al. Juliflorine: A potent natural peripheral anionic-site-binding inhibitor of acetylcholinesterase with calcium-channel blocking potential, a leading candidate for Alzheimer\u2019s disease therapy. Biochem. Biophys. Res. Commun. 2005;332:1171\u20131179. doi: 10.1016/j.bbrc.2005.05.068.", "ArticleIdList": ["10.1016/j.bbrc.2005.05.068", "16021692"]}, {"Citation": "Nukoolkarn V.S., Saen-oon S., Rungrotmongkol T., Hannongbua S., Ingkaninan K., Suwanborirux K. Petrosamine, a potent anticholinesterase pyridoacridine alkaloid from a Thai marine sponge Petrosia n. sp. Bioorg. Med. Chem. 2008;16:6560\u20136567. doi: 10.1016/j.bmc.2008.05.027.", "ArticleIdList": ["10.1016/j.bmc.2008.05.027", "18538575"]}, {"Citation": "Brunhofer G., Fallarero A., Karlsson D., Batista-Gonzalez A., Shinde P., Mohan C.G., Vuorela P. Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: The case of chelerythrine. Bioorg. Med. Chem. 2012;20:6669\u20136679. doi: 10.1016/j.bmc.2012.09.040.", "ArticleIdList": ["10.1016/j.bmc.2012.09.040", "23062825"]}, {"Citation": "Lopa S.S., Al-Amin M., Hasan M., Ahammed M., Islam K.M., Alam A.H.M., Tanaka T., Sadik M. Phytochemical analysis and cholinesterase inhibitory and antioxidant activities of Enhydra fluctuans relevant in the management of Alzheimer\u2019s disease. Int. J. Food Sci. 2021;2021:8862025. doi: 10.1155/2021/8862025.", "ArticleIdList": ["10.1155/2021/8862025", "PMC7815384", "33506005"]}, {"Citation": "Rodriguez S., Hug C., Todorov P., Moret N., Boswell S.A., Evans K., Zhou G., Johnson N.T., Hyman B.T., Sorger P.K., et al. Machine learning identifies candidates for drug repurposing in Alzheimer\u2019s disease. Nat. Commun. 2021;12:1033. doi: 10.1038/s41467-021-21330-0.", "ArticleIdList": ["10.1038/s41467-021-21330-0", "PMC7884393", "33589615"]}, {"Citation": "Park J.-C., Jang S.-Y., Lee D., Lee J., Kang U., Chang H., Kim H.J., Han S.-H., Seo J., Choi M., et al. A logical network-based drug-screening platform for Alzheimer\u2019s disease representing pathological features of human brain organoids. Nat. Commun. 2021;12:280. doi: 10.1038/s41467-020-20440-5.", "ArticleIdList": ["10.1038/s41467-020-20440-5", "PMC7804132", "33436582"]}, {"Citation": "Wang H.-Y., Pei Z., Lee K.-C., Lopez-Brignoni E., Nikolov B., Crowley C.A., Marsman M.R., Barbier R., Friedmann N., Burns L.H. PTI-125 reduces biomarkers of Alzheimer\u2019s disease in patients. J. Prev. Alzheimer\u2019s Dis. 2020;7:256\u2013264. doi: 10.14283/jpad.2020.6.", "ArticleIdList": ["10.14283/jpad.2020.6", "32920628"]}, {"Citation": "Anand P., Singh B. A review on cholinesterase inhibitors for Alzheimer\u2019s disease. Arch. Pharm. Res. 2013;36:375\u2013399. doi: 10.1007/s12272-013-0036-3.", "ArticleIdList": ["10.1007/s12272-013-0036-3", "23435942"]}, {"Citation": "Shaikh S., Verma A., Siddiqui S., Syed S.A., Syed M.D.R., Shakil S., Biswas D., Singh D., Mohmmad H.S., Shakil S. Current acetylcholinesterase-inhibitors: A neuroinformatics perspective. CNS Neurol. Disorders\u2014Drug Targets (Former. Curr. Drug Targets\u2014CNS Neurol. Disord.) 2014;13:391\u2013401. doi: 10.2174/18715273113126660166.", "ArticleIdList": ["10.2174/18715273113126660166", "24059296"]}, {"Citation": "Sharma K. Cholinesterase inhibitors as Alzheimer\u2019s therapeutics. Mol. Med. Rep. 2019;20:1479\u20131487. doi: 10.3892/mmr.2019.10374.", "ArticleIdList": ["10.3892/mmr.2019.10374", "PMC6625431", "31257471"]}, {"Citation": "Becker R.E., Greig N.H., Lahiri D.K., Bledsoe J., Majercik S., Ballard C., Aarsland D., Schneider L.S., Flanagan D., Govindarajan R., et al. (-)-Phenserine and Inhibiting Pre-Programmed Cell Death: In Pursuit of a Novel Intervention for Alzheimer\u2019s Disease. Curr. Alzheimer Res. 2018;15:883\u2013891. doi: 10.2174/1567205015666180110120026.", "ArticleIdList": ["10.2174/1567205015666180110120026", "PMC6039273", "29318971"]}, {"Citation": "Luo W., Yu Q.s., Zhan M., Parrish D., Deschamps J.R., Kulkarni S.S., Holloway H.W., Alley G.M., Lahiri D.K., Brossi A., et al. Novel anticholinesterases based on the molecular skeletons of furobenzofuran and methanobenzodioxepine. J. Med. Chem. 2005;48:986\u2013994. doi: 10.1021/jm049309+.", "ArticleIdList": ["10.1021/jm049309+", "15715468"]}, {"Citation": "McHardy S.F., Wang H.-Y.L., McCowen S.V., Valdez M.C. Recent advances in acetylcholinesterase inhibitors and reactivators: An update on the patent literature (2012\u20132015) Expert Opin. Ther. Patents. 2017;27:455\u2013476. doi: 10.1080/13543776.2017.1272571.", "ArticleIdList": ["10.1080/13543776.2017.1272571", "27967267"]}, {"Citation": "Liu J., Chang L., Song Y., Li H., Wu Y. The role of NMDA receptors in Alzheimer\u2019s disease. Front. Neurosci. 2019;13:43. doi: 10.3389/fnins.2019.00043.", "ArticleIdList": ["10.3389/fnins.2019.00043", "PMC6375899", "30800052"]}, {"Citation": "Alam P., Alajmi M.F., Arbab A.H., Parvez M.K., Siddiqui N.A., Alqasoumi S.I., Al-Rehaily A.J., Al-Dosari M.S., Basudan O.A. Comparative study of antioxidant activity and validated RP-HPTLC analysis of rutin in the leaves of different Acacia species grown in Saudi Arabia. Saudi Pharm. J. 2017;25:715\u2013723. doi: 10.1016/j.jsps.2016.10.010.", "ArticleIdList": ["10.1016/j.jsps.2016.10.010", "PMC5506739", "28725144"]}, {"Citation": "Breijyeh Z., Karaman R. Comprehensive review on Alzheimer\u2019s disease: Causes and treatment. Molecules. 2020;25:5789. doi: 10.3390/molecules25245789.", "ArticleIdList": ["10.3390/molecules25245789", "PMC7764106", "33302541"]}, {"Citation": "Bui T.T., Nguyen T.H. Natural product for the treatment of Alzheimer\u2019s disease. J. Basic Clin. Physiol. Pharm. 2017;28:413\u2013423. doi: 10.1515/jbcpp-2016-0147.", "ArticleIdList": ["10.1515/jbcpp-2016-0147", "28708573"]}, {"Citation": "Granzotto C., Sutherland K., Arslanoglu J., Ferguson G.A. Discrimination of Acacia gums by MALDI-TOF MS: Applications to micro-samples from works of art. Microchem. J. 2019;144:229\u2013241. doi: 10.1016/j.microc.2018.08.058.", "ArticleIdList": ["10.1016/j.microc.2018.08.058"]}, {"Citation": "Feng X., Liang N., Zhu D., Gao Q., Peng L., Dong H., Yue Q., Liu H., Bao L., Zhang J., et al. Resveratrol inhibits \u03b2-amyloid-induced neuronal apoptosis through regulation of SIRT1-ROCK1 signaling pathway. PLoS ONE. 2013;8:e59888. doi: 10.1371/journal.pone.0059888.", "ArticleIdList": ["10.1371/journal.pone.0059888", "PMC3610881", "23555824"]}, {"Citation": "Porquet Costa D., Casades\u00fas G., Bayod Gimeno S., Vicente A., Canudas Teixid\u00f3 A.-M., Vilaplana i Hortensi J., Pelegr\u00ed i Gabald\u00e0 C., Sanfeliu i Pujol C., Camins Espuny A., Pall\u00e0s i Lliber\u00eda M. AGE. Volume 35. Springer; Berlin, German: 2013. Dietary Resveratrol Prevents Alzheimer\u2019s Markers and Increases Life Span in SAMP8; pp. 1851\u20131865.", "ArticleIdList": ["PMC3776096", "23129026"]}, {"Citation": "Zhou X., Yuan L., Zhao X., Hou C., Ma W., Yu H., Xiao R. Genistein antagonizes inflammatory damage induced by \u03b2-amyloid peptide in microglia through TLR4 and NF-\u03baB. Nutrition. 2014;30:90\u201395. doi: 10.1016/j.nut.2013.06.006.", "ArticleIdList": ["10.1016/j.nut.2013.06.006", "24290604"]}, {"Citation": "Castillo W.O., Palomino N.V., Takahashi C.S., Giuliatti S. Genistein and galantamine combinations decrease \u03b2-amyloid peptide (1\u201342)\u2013induced genotoxicity and cell death in SH-SY5Y cell line: An in vitro and in silico approach for mimic of Alzheimer\u2019s Disease. Neurotox. Res. 2020;38:691\u2013706. doi: 10.1007/s12640-020-00243-8.", "ArticleIdList": ["10.1007/s12640-020-00243-8", "32613603"]}, {"Citation": "Duan X., Li Y., Xu F., Ding H. Study on the neuroprotective effects of Genistein on Alzheimer\u2019s disease. Brain Behav. 2021;11:e02100. doi: 10.1002/brb3.2100.", "ArticleIdList": ["10.1002/brb3.2100", "PMC8119804", "33704934"]}, {"Citation": "Bieschke J., Russ J., Friedrich R.P., Ehrnhoefer D.E., Wobst H., Neugebauer K., Wanker E.E. EGCG remodels mature \u03b1-synuclein and amyloid-\u03b2 fibrils and reduces cellular toxicity. Proc. Natl. Acad. Sci. USA. 2010;107:7710\u20137715. doi: 10.1073/pnas.0910723107.", "ArticleIdList": ["10.1073/pnas.0910723107", "PMC2867908", "20385841"]}, {"Citation": "Rezai-Zadeh K., Shytle D., Sun N., Mori T., Hou H., Jeanniton D., Ehrhart J., Townsend K., Zeng J., Morgan D., et al. Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice. J. Neurosci. 2005;25:8807\u20138814. doi: 10.1523/JNEUROSCI.1521-05.2005.", "ArticleIdList": ["10.1523/JNEUROSCI.1521-05.2005", "PMC6725500", "16177050"]}, {"Citation": "Eid H.M., Nachar A., Thong F., Sweeney G., Haddad P.S. The molecular basis of the antidiabetic action of quercetin in cultured skeletal muscle cells and hepatocytes. Pharmacogn. Mag. 2015;11:74\u201381.", "ArticleIdList": ["PMC4329636", "25709214"]}, {"Citation": "Ansari M.A., Abdul H.M., Joshi G., Opii W.O., Butterfield D.A. Protective effect of quercetin in primary neurons against A\u03b2 (1\u201342): Relevance to Alzheimer\u2019s disease. J. Nutr. Biochem. 2009;20:269\u2013275. doi: 10.1016/j.jnutbio.2008.03.002.", "ArticleIdList": ["10.1016/j.jnutbio.2008.03.002", "PMC2737260", "18602817"]}, {"Citation": "Sabogal-Gu\u00e1queta A.M., Mu\u00f1oz-Manco J.I., Ram\u00edrez-Pineda J.R., Lamprea-Rodriguez M., Osorio E., Cardona-G\u00f3mez G.P. The flavonoid quercetin ameliorates Alzheimer\u2019s disease pathology and protects cognitive and emotional function in aged triple transgenic Alzheimer\u2019s disease model mice. Neuropharmacology. 2015;93:134\u2013145. doi: 10.1016/j.neuropharm.2015.01.027.", "ArticleIdList": ["10.1016/j.neuropharm.2015.01.027", "PMC4387064", "25666032"]}, {"Citation": "Bagheri M., Joghataei M.-T., Mohseni S., Roghani M. Genistein ameliorates learning and memory deficits in amyloid \u03b2 (1\u201340) rat model of Alzheimer\u2019s disease. Neurobiol. Learn. Mem. 2011;95:270\u2013276. doi: 10.1016/j.nlm.2010.12.001.", "ArticleIdList": ["10.1016/j.nlm.2010.12.001", "21144907"]}, {"Citation": "Wang D.-M., Li S.-Q., Wu W.-L., Zhu X.-Y., Wang Y., Yuan H.-Y. Effects of long-term treatment with quercetin on cognition and mitochondrial function in a mouse model of Alzheimer\u2019s disease. Neurochem. Res. 2014;39:1533\u20131543. doi: 10.1007/s11064-014-1343-x.", "ArticleIdList": ["10.1007/s11064-014-1343-x", "24893798"]}, {"Citation": "Vargas-Restrepo F., Sabogal-Gu\u00e1queta A.M., Cardona-G\u00f3mez G.P. Quercetin ameliorates inflammation in CA1 hippocampal region in aged triple transgenic Alzheimer\u2019s disease mice model. Biom\u00e9dica. 2018;38((Suppl. S1)):62\u201369.", "ArticleIdList": ["29809330"]}, {"Citation": "Wang C., Zhang X., Teng Z., Zhang T., Li Y. Downregulation of PI3K/Akt/mTOR signaling pathway in curcumin-induced autophagy in APP/PS1 double transgenic mice. Eur. J. Pharm. 2014;740:312\u2013320. doi: 10.1016/j.ejphar.2014.06.051.", "ArticleIdList": ["10.1016/j.ejphar.2014.06.051", "25041840"]}, {"Citation": "Jaroonwitchawan T., Chaicharoenaudomrung N., Namkaew J., Noisa P. Curcumin attenuates paraquat-induced cell death in human neuroblastoma cells through modulating oxidative stress and autophagy. Neurosci. Lett. 2017;636:40\u201347. doi: 10.1016/j.neulet.2016.10.050.", "ArticleIdList": ["10.1016/j.neulet.2016.10.050", "27793699"]}, {"Citation": "Huang H.-C., Tang D., Xu K., Jiang Z.-F. Curcumin attenuates amyloid-\u03b2-induced tau hyperphosphorylation in human neuroblastoma SH-SY5Y cells involving PTEN/Akt/GSK-3\u03b2 signaling pathway. J. Recept. Signal Transduct. 2014;34:26\u201337. doi: 10.3109/10799893.2013.848891.", "ArticleIdList": ["10.3109/10799893.2013.848891", "24188406"]}, {"Citation": "Hong Y., An Z. Hesperidin attenuates learning and memory deficits in APP/PS1 mice through activation of Akt/Nrf2 signaling and inhibition of RAGE/NF-\u03baB signaling. Arch. Pharm. Res. 2018;41:655\u2013663. doi: 10.1007/s12272-015-0662-z.", "ArticleIdList": ["10.1007/s12272-015-0662-z", "26391026"]}, {"Citation": "Li C., Zug C., Qu H., Schluesener H., Zhang Z. Hesperidin ameliorates behavioral impairments and neuropathology of transgenic APP/PS1 mice. Behav. Brain Res. 2015;281:32\u201342. doi: 10.1016/j.bbr.2014.12.012.", "ArticleIdList": ["10.1016/j.bbr.2014.12.012", "25510196"]}, {"Citation": "Huang S.-M., Tsai S.-Y., Lin J.-A., Wu C.-H., Yen G.-C. Cytoprotective effects of hesperetin and hesperidin against amyloid \u03b2-induced impairment of glucose transport through downregulation of neuronal autophagy. Mol. Nutr. Food Res. 2012;56:601\u2013609. doi: 10.1002/mnfr.201100682.", "ArticleIdList": ["10.1002/mnfr.201100682", "22383310"]}, {"Citation": "Fan Y., Wang N., Rocchi A., Zhang W., Vassar R., Zhou Y., He C. Identification of natural products with neuronal and metabolic benefits through autophagy induction. Autophagy. 2017;13:41\u201356. doi: 10.1080/15548627.2016.1240855.", "ArticleIdList": ["10.1080/15548627.2016.1240855", "PMC5240827", "27791467"]}, {"Citation": "Li R., Zhang Y., Rasool S., Geetha T., Babu J.R. Effects and underlying mechanisms of bioactive compounds on type 2 diabetes mellitus and Alzheimer\u2019s disease. Oxid. Med. Cell. Longev. 2019;2019:8165707. doi: 10.1155/2019/8165707.", "ArticleIdList": ["10.1155/2019/8165707", "PMC6360036", "30800211"]}, {"Citation": "Qu M., Li L., Chen C., Li M., Pei L., Chu F., Yang J., Yu Z., Wang D., Zhou Z. Protective effects of lycopene against amyloid \u03b2-induced neurotoxicity in cultured rat cortical neurons. Neurosci. Lett. 2011;505:286\u2013290. doi: 10.1016/j.neulet.2011.10.048.", "ArticleIdList": ["10.1016/j.neulet.2011.10.048", "22044877"]}, {"Citation": "Guo P., Zhang B., Zhao J., Wang C., Wang Z., Liu A., Du G. Medicine-Food Herbs against Alzheimer\u2019s Disease: A Review of Their Traditional Functional Features, Substance Basis, Clinical Practices and Mechanisms of Action. Molecules. 2022;27:901. doi: 10.3390/molecules27030901.", "ArticleIdList": ["10.3390/molecules27030901", "PMC8839204", "35164167"]}, {"Citation": "Zhang L., Granick S. How to stabilize phospholipid liposomes (using nanoparticles) Nano Lett. 2006;6:694\u2013698. doi: 10.1021/nl052455y.", "ArticleIdList": ["10.1021/nl052455y", "16608266"]}, {"Citation": "Pattni B.S., Chupin V.V., Torchilin V.P. New Developments in Liposomal Drug Delivery. Chem. Rev. 2015;115:10938\u201310966. doi: 10.1021/acs.chemrev.5b00046.", "ArticleIdList": ["10.1021/acs.chemrev.5b00046", "26010257"]}, {"Citation": "Wang S., Su R., Nie S., Sun M., Zhang J., Wu D., Moustaid-Moussa N. Application of nanotechnology in improving bioavailability and bioactivity of diet-derived phytochemicals. J. Nutr. Biochem. 2014;25:363\u2013376. doi: 10.1016/j.jnutbio.2013.10.002.", "ArticleIdList": ["10.1016/j.jnutbio.2013.10.002", "PMC3959237", "24406273"]}, {"Citation": "Moballegh-Nasery M., Mandegary A., Eslaminejad T., Zeinali M., Pardakhti A., Behnam B., Mohammadi M. Cytotoxicity evaluation of curcumin-loaded affibody-decorated liposomes against breast cancerous cell lines. J. Liposome Res. 2021;31:189\u2013194. doi: 10.1080/08982104.2020.1755981.", "ArticleIdList": ["10.1080/08982104.2020.1755981", "32292087"]}, {"Citation": "Narayanan N.K., Nargi D., Randolph C., Narayanan B.A. Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice. Int. J. Cancer. 2009;125:1\u20138. doi: 10.1002/ijc.24336.", "ArticleIdList": ["10.1002/ijc.24336", "19326431"]}, {"Citation": "Yekollu S.K., Thomas R., O\u2019Sullivan B. Targeting curcusomes to inflammatory dendritic cells inhibits NF-\u03baB and improves insulin resistance in obese mice. Diabetes. 2011;60:2928\u20132938. doi: 10.2337/db11-0275.", "ArticleIdList": ["10.2337/db11-0275", "PMC3198103", "21885868"]}, {"Citation": "Y\u00fccel \u00c7., Karatoprak G.\u015e., Akta\u015f Y. Nanoliposomal Resveratrol as a Novel Approach to Treatment of Diabetes Mellitus. J. Nanosci. Nanotechnol. 2018;18:3856\u20133864. doi: 10.1166/jnn.2018.15247.", "ArticleIdList": ["10.1166/jnn.2018.15247", "29442719"]}, {"Citation": "Baowen Q., Yulin Z., Xin W., Wenjing X., Hao Z., Zhizhi C., Xingmei D., Xia Z., Yuquan W., Lijuan C. A further investigation concerning correlation between anti-fibrotic effect of liposomal quercetin and inflammatory cytokines in pulmonary fibrosis. Eur. J. Pharmacol. 2010;642:134\u2013139. doi: 10.1016/j.ejphar.2010.05.019.", "ArticleIdList": ["10.1016/j.ejphar.2010.05.019", "20510684"]}, {"Citation": "Khan M.A., Aldebasi Y.H., Alsuhaibani S.A., AlSahli M.A., Alzohairy M.A., Khan A., Younus H. Therapeutic potential of thymoquinone liposomes against the systemic infection of Candida albicans in diabetic mice. PLoS ONE. 2018;13:e0208951. doi: 10.1371/journal.pone.0208951.", "ArticleIdList": ["10.1371/journal.pone.0208951", "PMC6320018", "30589842"]}, {"Citation": "Zhang Y. Effect of apigenin-loaded nanoliposomes on myocardial cells apoptosis induced by diabetic cardiomyopathy. Her. Med. 2019;38:555\u2013559."}, {"Citation": "Shu Q., Wu J., Chen Q. Synthesis, Characterization of Liposomes Modified with Biosurfactant MEL-A Loading Betulinic Acid and Its Anticancer Effect in HepG2 Cell. Molecules. 2019;24:3939. doi: 10.3390/molecules24213939.", "ArticleIdList": ["10.3390/molecules24213939", "PMC6864557", "31683639"]}, {"Citation": "Bay\u00f3n-Cordero L., Alkorta I., Arana L. Application of Solid Lipid Nanoparticles to Improve the Efficiency of Anticancer Drugs. Nanomaterials. 2019;9:474. doi: 10.3390/nano9030474.", "ArticleIdList": ["10.3390/nano9030474", "PMC6474076", "30909401"]}, {"Citation": "Young N.A., Bruss M.S., Gardner M., Willis W.L., Mo X., Valiente G.R., Cao Y., Liu Z., Jarjour W.N., Wu L.-C. Oral Administration of Nano-Emulsion Curcumin in Mice Suppresses Inflammatory-Induced NF\u03baB Signaling and Macrophage Migration. PLoS ONE. 2014;9:e111559. doi: 10.1371/journal.pone.0111559.", "ArticleIdList": ["10.1371/journal.pone.0111559", "PMC4219720", "25369140"]}, {"Citation": "Joshi R.P., Negi G., Kumar A., Pawar Y.B., Munjal B., Bansal A.K., Sharma S.S. SNEDDS curcumin formulation leads to enhanced protection from pain and functional deficits associated with diabetic neuropathy: An insight into its mechanism for neuroprotection. Nanomed. Nanotechnol. Biol. Med. 2013;9:776\u2013785. doi: 10.1016/j.nano.2013.01.001.", "ArticleIdList": ["10.1016/j.nano.2013.01.001", "23347896"]}, {"Citation": "Sessa M., Balestrieri M.L., Ferrari G., Servillo L., Castaldo D., D\u2019Onofrio N., Dons\u00ec F., Tsao R. Bioavailability of encapsulated resveratrol into nanoemulsion-based delivery systems. Food Chem. 2014;147:42\u201350. doi: 10.1016/j.foodchem.2013.09.088.", "ArticleIdList": ["10.1016/j.foodchem.2013.09.088", "24206683"]}, {"Citation": "Jeevanandam J., Aing Y.S., Chan Y.S., Pan S., Danquah M.K. Chapter 3\u2014Nanoformulation and Application of Phytochemicals as Antimicrobial Agents. In: Grumezescu A.M., editor. Antimicrobial Nanoarchitectonics. Elsevier; Amsterdam, The Netherlands: 2017. pp. 61\u201382."}, {"Citation": "More M.P., Pardeshi S.R., Pardeshi C.V., Sonawane G.A., Shinde M.N., Deshmukh P.K., Naik J.B., Kulkarni A.D. Recent advances in phytochemical-based Nano-formulation for drug-resistant Cancer. Med. Drug Discov. 2021;10:100082. doi: 10.1016/j.medidd.2021.100082.", "ArticleIdList": ["10.1016/j.medidd.2021.100082"]}, {"Citation": "Wan S., Zhang L., Quan Y., Wei K. Resveratrol-loaded PLGA nanoparticles: Enhanced stability, solubility and bioactivity of resveratrol for non-alcoholic fatty liver disease therapy. R. Soc. Open Sci. 2018;5:181457. doi: 10.1098/rsos.181457.", "ArticleIdList": ["10.1098/rsos.181457", "PMC6281916", "30564426"]}, {"Citation": "Sanna V., Siddiqui I.A., Sechi M., Mukhtar H. Resveratrol-loaded nanoparticles based on poly(epsilon-caprolactone) and poly(D,L-lactic-co-glycolic acid)\u2014Poly(ethylene glycol) blend for prostate cancer treatment. Mol. Pharm. 2013;10:3871\u20133881. doi: 10.1021/mp400342f.", "ArticleIdList": ["10.1021/mp400342f", "PMC4100701", "23968375"]}, {"Citation": "Samadder A., Abraham S.K., Khuda-Bukhsh A.R. Nanopharmaceutical approach using pelargonidin towards enhancement of efficacy for prevention of alloxan-induced DNA damage in L6 cells via activation of PARP and p53. Environ. Toxicol. Pharmacol. 2016;43:27\u201337. doi: 10.1016/j.etap.2016.02.010.", "ArticleIdList": ["10.1016/j.etap.2016.02.010", "26943895"]}, {"Citation": "Mukerjee A., Vishwanatha J.K. Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy. Anticancer Res. 2009;29:3867\u20133875.", "ArticleIdList": ["19846921"]}, {"Citation": "Gomes C., Moreira R.G., Castell-Perez E. Poly (DL-lactide-co-glycolide) (PLGA) nanoparticles with entrapped trans-cinnamaldehyde and eugenol for antimicrobial delivery applications. J. Food Sci. 2011;76:N16\u2013N24. doi: 10.1111/j.1750-3841.2010.01985.x.", "ArticleIdList": ["10.1111/j.1750-3841.2010.01985.x", "21535781"]}, {"Citation": "Fan S., Zheng Y., Liu X., Fang W., Chen X., Liao W., Jing X., Lei M., Tao E., Ma Q., et al. Curcumin-loaded PLGA-PEG nanoparticles conjugated with B6 peptide for potential use in Alzheimer\u2019s disease. Drug Deliv. 2018;25:1091\u20131102. doi: 10.1080/10717544.2018.1461955.", "ArticleIdList": ["10.1080/10717544.2018.1461955", "PMC6116673", "30107760"]}, {"Citation": "Brahmkhatri V.P., Sharma N., Sunanda P., D\u2019Souza A., Raghothama S., Atreya H.S. Curcumin nanoconjugate inhibits aggregation of N-terminal region (A\u03b2-16) of an amyloid beta peptide. New J. Chem. 2018;42:19881\u201319892. doi: 10.1039/C8NJ03541E.", "ArticleIdList": ["10.1039/C8NJ03541E"]}, {"Citation": "Tiwari S.K., Agarwal S., Seth B., Yadav A., Nair S., Bhatnagar P., Karmakar M., Kumari M., Chauhan L.K.S., Patel D.K., et al. Curcumin-Loaded Nanoparticles Potently Induce Adult Neurogenesis and Reverse Cognitive Deficits in Alzheimer\u2019s Disease Model via Canonical Wnt/\u03b2-Catenin Pathway. ACS Nano. 2014;8:76\u2013103. doi: 10.1021/nn405077y.", "ArticleIdList": ["10.1021/nn405077y", "24467380"]}, {"Citation": "Doggui S., Sahni J.K., Arseneault M., Dao L., Ramassamy C. Neuronal Uptake and Neuroprotective Effect of Curcumin-Loaded PLGA Nanoparticles on the Human SK-N-SH Cell Line. JAD. 2012;30:377\u2013392. doi: 10.3233/JAD-2012-112141.", "ArticleIdList": ["10.3233/JAD-2012-112141", "22426019"]}, {"Citation": "Ray B., Bisht S., Maitra A., Maitra A., Lahiri D.K. Neuroprotective and Neurorescue Effects of a Novel Polymeric Nanoparticle Formulation of Curcumin (NanoCurcTM) in the Neuronal Cell Culture and Animal Model: Implications for Alzheimer\u2019s Disease. J. Alzheimer\u2019s Dis. 2011;23:61\u201377. doi: 10.3233/JAD-2010-101374.", "ArticleIdList": ["10.3233/JAD-2010-101374", "PMC3303195", "20930270"]}, {"Citation": "Mathew A., Aravind A., Brahatheeswaran D., Fukuda T., Nagaoka Y., Hasumura T., Iwai S., Morimoto H., Yoshida Y., Maekawa T., et al. Amyloid-Binding Aptamer Conjugated Curcumin\u2013PLGA Nanoparticle for Potential Use in Alzheimer\u2019s Disease. BioNanoScience. 2012;2:83\u201393. doi: 10.1007/s12668-012-0040-y.", "ArticleIdList": ["10.1007/s12668-012-0040-y"]}, {"Citation": "Hoppe J.B., Coradini K., Frozza R.L., Oliveira C.M., Meneghetti A.B., Bernardi A., Pires E.S., Beck R.C.R., Salbego C.G. Free and nanoencapsulated curcumin suppress \u03b2-amyloid-induced cognitive impairments in rats: Involvement of BDNF and Akt/GSK-3\u03b2 signaling pathway. Neurobiol. Learn. Mem. 2013;106:134\u2013144. doi: 10.1016/j.nlm.2013.08.001.", "ArticleIdList": ["10.1016/j.nlm.2013.08.001", "23954730"]}, {"Citation": "Mourtas S., Canovi M., Zona C., Aurilia D., Niarakis A., Ferla B.L., Salmona M., Nicotra F., Gobbi M., Antimisiaris S.G. Curcumin-decorated nanoliposomes with very high affinity for amyloid-b1-42 peptide. Biomaterials. 2011;32:1635\u20131645. doi: 10.1016/j.biomaterials.2010.10.027.", "ArticleIdList": ["10.1016/j.biomaterials.2010.10.027", "21131044"]}, {"Citation": "Moradi S.Z., Momtaz S., Bayrami Z., Farzaei M.H., Abdollahi M. Nanoformulations of Herbal Extracts in Treatment of Neurodegenerative Disorders. Front. Bioeng. Biotechnol. 2020;8:238. doi: 10.3389/fbioe.2020.00238.", "ArticleIdList": ["10.3389/fbioe.2020.00238", "PMC7154137", "32318551"]}, {"Citation": "Abozaid O.A.R., Sallam M.W., El-Sonbaty S., Aziza S., Emad B., Ahmed E.S.A. Resveratrol-Selenium Nanoparticles Alleviate Neuroinflammation and Neurotoxicity in a Rat Model of Alzheimer\u2019s Disease by Regulating Sirt1/miRNA-134/GSK3\u03b2 Expression. Biol. Trace Element Res. 2022;200:5104\u20135114. doi: 10.1007/s12011-021-03073-7.", "ArticleIdList": ["10.1007/s12011-021-03073-7", "35059981"]}, {"Citation": "Yang L., Wang W., Chen J., Wang N., Zheng G. A comparative study of resveratrol and resveratrol-functional selenium nanoparticles: Inhibiting amyloid \u03b2 aggregation and reactive oxygen species formation properties. J. Biomed. Mater. Res. A. 2018;106:3034\u20133041. doi: 10.1002/jbm.a.36493.", "ArticleIdList": ["10.1002/jbm.a.36493", "30295993"]}, {"Citation": "Li C., Wang N., Zheng G., Yang L. Oral Administration of Resveratrol-Selenium-Peptide Nanocomposites Alleviates Alzheimer\u2019s Disease-like Pathogenesis by Inhibiting A\u03b2 Aggregation and Regulating Gut Microbiota. ACS Appl. Mater. Interfaces. 2021;13:46406\u201346420. doi: 10.1021/acsami.1c14818.", "ArticleIdList": ["10.1021/acsami.1c14818", "34569225"]}, {"Citation": "Lu X., Ji C., Xu H., Li X., Ding H., Ye M., Zhu Z., Ding D., Jiang X., Ding X., et al. Resveratrol-loaded polymeric micelles protect cells from A\u03b2-induced oxidative stress. Int. J. Pharm. 2009;375:89\u201396. doi: 10.1016/j.ijpharm.2009.03.021.", "ArticleIdList": ["10.1016/j.ijpharm.2009.03.021", "19481694"]}, {"Citation": "Frozza R.L., Bernardi A., Hoppe J.B., Meneghetti A.B., Battastini A.M.O., Pohlmann A.R., Guterres S.S., Salbego C. Lipid-Core Nanocapsules Improve the Effects of Resveratrol Against A\u03b2-Induced Neuroinflammation. J. Biomed. Nanotechnol. 2013;9:2086\u20132104. doi: 10.1166/jbn.2013.1709.", "ArticleIdList": ["10.1166/jbn.2013.1709", "24266263"]}, {"Citation": "Zhang J., Zhou X., Yu Q., Yang L., Sun D., Zhou Y., Liu J. Epigallocatechin-3-gallate (EGCG)-Stabilized Selenium Nanoparticles Coated with Tet-1 Peptide To Reduce Amyloid-\u03b2 Aggregation and Cytotoxicity. ACS Appl. Mater. Interfaces. 2014;6:8475\u20138487. doi: 10.1021/am501341u.", "ArticleIdList": ["10.1021/am501341u", "24758520"]}, {"Citation": "Singh N.A., Mandal A.K.A., Khan Z.A. Inhibition of Al(III)-Induced A\u03b242 Fibrillation and Reduction of Neurotoxicity by Epigallocatechin-3-Gallate Nanoparticles. J. Biomed. Nanotechnol. 2018;14:1147\u20131158. doi: 10.1166/jbn.2018.2552.", "ArticleIdList": ["10.1166/jbn.2018.2552", "29843879"]}, {"Citation": "Cano A., Ettcheto M., Chang J.-H., Barroso E., Espina M., K\u00fchne B.A., Barenys M., Auladell C., Folch J., Souto E.B., et al. Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer\u2019s disease mice model. J. Control. Release. 2019;301:62\u201375. doi: 10.1016/j.jconrel.2019.03.010.", "ArticleIdList": ["10.1016/j.jconrel.2019.03.010", "PMC6510952", "30876953"]}, {"Citation": "Rifaai R.A., Mokhemer S.A., Saber E.A., El-Aleem S.A.A., El-Tahawy N.F.G. Neuroprotective effect of quercetin nanoparticles: A possible prophylactic and therapeutic role in alzheimer\u2019s disease. J. Chem. Neuroanat. 2020;107:101795. doi: 10.1016/j.jchemneu.2020.101795.", "ArticleIdList": ["10.1016/j.jchemneu.2020.101795", "32464160"]}, {"Citation": "Moreno L.C.G.E.I., Puerta E., Su\u00e1rez-Santiago J.E., Santos-Magalh\u00e3es N.S., Ramirez M.J., Irache J.M. Effect of the oral administration of nanoencapsulated quercetin on a mouse model of Alzheimer\u2019s disease. Int. J. Pharm. 2017;517:50\u201357. doi: 10.1016/j.ijpharm.2016.11.061.", "ArticleIdList": ["10.1016/j.ijpharm.2016.11.061", "27915007"]}, {"Citation": "Sun D., Li N., Zhang W., Zhao Z., Mou Z., Huang D., Liu J., Wang W. Design of PLGA-functionalized quercetin nanoparticles for potential use in Alzheimer\u2019s disease. Colloids Surf. B Biointerfaces. 2016;148:116\u2013129. doi: 10.1016/j.colsurfb.2016.08.052.", "ArticleIdList": ["10.1016/j.colsurfb.2016.08.052", "27591943"]}, {"Citation": "Liu Y., Zhou H., Yin T., Gong Y., Yuan G., Chen L., Liu J. Quercetin-modified gold-palladium nanoparticles as a potential autophagy inducer for the treatment of Alzheimer\u2019s disease. J. Colloid Interface Sci. 2019;552:388\u2013400. doi: 10.1016/j.jcis.2019.05.066.", "ArticleIdList": ["10.1016/j.jcis.2019.05.066", "31151017"]}, {"Citation": "Bondi M.L., Montana G., Craparo E., Picone P., Capuano G., Carlo M.D., Giammona G. Ferulic Acid-Loaded Lipid Nanostructures as Drug Delivery Systems for Alzheimers Disease: Preparation, Characterization and Cytotoxicity Studies. Curr. Nanosci. 2009;5:26\u201332. doi: 10.2174/157341309787314656.", "ArticleIdList": ["10.2174/157341309787314656"]}, {"Citation": "Trombino S., Cassano R., Ferrarelli T., Barone E., Picci N., Mancuso C. Trans-ferulic acid-based solid lipid nanoparticles and their antioxidant effect in rat brain microsomes. Colloids Surf. B Biointerfaces. 2013;109:273\u2013279. doi: 10.1016/j.colsurfb.2013.04.005.", "ArticleIdList": ["10.1016/j.colsurfb.2013.04.005", "23668982"]}, {"Citation": "Kulkarni P.V., Roney C.A., Antich P.P., Bonte F.J., Raghu A.V., Aminabhavi T.M. Quinoline- n -butylcyanoacrylate-based nanoparticles for brain targeting for the diagnosis of Alzheimer\u2019s disease. WIREs Nanomed. Nanobiotechnol. 2010;2:35\u201347. doi: 10.1002/wnan.59.", "ArticleIdList": ["10.1002/wnan.59", "20049829"]}, {"Citation": "Md S., Gan S.Y., Haw Y.H., Ho C.L., Wong S., Choudhury H. In vitro neuroprotective effects of naringenin nanoemulsion against \u03b2-amyloid toxicity through the regulation of amyloidogenesis and tau phosphorylation. Int. J. Biol. Macromol. 2018;118:1211\u20131219. doi: 10.1016/j.ijbiomac.2018.06.190.", "ArticleIdList": ["10.1016/j.ijbiomac.2018.06.190", "30001606"]}, {"Citation": "Patel D.A., Henry J.E., Good T.A. Attenuation of \u03b2-amyloid-induced toxicity by sialic-acid-conjugated dendrimers: Role of sialic acid attachment. Brain Res. 2007;1161:95\u2013105. doi: 10.1016/j.brainres.2007.05.055.", "ArticleIdList": ["10.1016/j.brainres.2007.05.055", "PMC2031224", "17604005"]}, {"Citation": "Wang Z.H., Wang Z.Y., Sun C.S., Wang C.Y., Jiang T.Y., Wang S.L. Trimethylated chitosan-conjugated PLGA nanoparticles for the delivery of drugs to the brain. Biomaterials. 2010;31:908\u2013915. doi: 10.1016/j.biomaterials.2009.09.104.", "ArticleIdList": ["10.1016/j.biomaterials.2009.09.104", "19853292"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "11", "Day": "6"}, {"Year": "2022", "Month": "12", "Day": "4"}, {"Year": "2022", "Month": "12", "Day": "9"}, {"Year": "2022", "Month": "12", "Day": "23", "Hour": "1", "Minute": "51"}, {"Year": "2022", "Month": "12", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "12", "Day": "27", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "12", "Day": "19"}], "PublicationStatus": "epublish", "ArticleIdList": ["36558176", "PMC9781052", "10.3390/molecules27249043", "molecules27249043"]}}], "PubmedBookArticle": []}